Funding Received
$13.5 Million in 2 Rounds from 5 Investors
Most Recent Funding
$3.5 Million Grant on February 28, 2012
Headquarters:
Vienna
Description:
Miracor Medical Systems develops a pressure-controlled intermittent coronary sinus occlusion technology for heart patients.
Categories:
Health Care
Website:
http://www.miracormedical.com

Company Details

Update

Based in Vienna, Austria, privately held Miracor is commercializing a unique and potentially disruptive technology, PICSO®, for acute coronary syndrome (ACS), heart failure, and cardiac surgery patients. The Company’s objective is to establish PICSO® as the standard of care for heart attack patients, thereby improving their quality of life. The initial market opportunity for PICSO® is 30% of all ACS patients treated per year, which translates into more than 350,000 patients in the U.S. and Europe.

The Miracor PICSO® Impulse System is CE-marked and can be used during coronary revascularization procedures following myocardial infarction and other types of acute coronary syndromes to intermittently increase the pressure in the coronary venous system. The technology is for investigational use only in the United States at this time.

Current Team (3)

Update

Investors (5)

Update

Offices/Locations (1)

Update
  • Office

    Gumpendorferstrasse 139 Top 1.05

    Vienna, A-1060

    AUT

Images (1)

Update
  • 8201a5379e9c34364db020fc1318b180